Introduction
============

Over the last century, there have been several medical innovations offering multiple viable treatment options for most diseases. In addition, increasing patient's awareness and autonomy have made it necessary to consider patient's preferences and values in the treatment decision-making process.[@b1-ppa-12-2309] Patient's preference refers to a patient's perspective, expectations, and goals for health, as well as the processes involved in evaluating the potential benefits, harms, and costs of each management option offered to the patient.[@b2-ppa-12-2309] Patient's value refers to the benefit that a patient assigns to a given treatment option.[@b3-ppa-12-2309] Health care policymakers recommend that the patient's preferences should be considered through active involvement of patient in the treatment decision-making process.[@b4-ppa-12-2309]--[@b7-ppa-12-2309] The National Academy of Medicine (formerly the Institute of Medicine),[@b8-ppa-12-2309] the Guidelines International Network,[@b9-ppa-12-2309] and Appraisal of Guidelines Research and Evaluation II (AGREE II)[@b10-ppa-12-2309] all recommend incorporating patient's values in the development of clinical practice guidelines. A clinical practice guideline that does not consider patient's preferences may provide recommendations that are not optimal or consistent with patient's preferences or values.[@b11-ppa-12-2309] For example, the US Preventive Service Task Force clinical practice guideline recommends that the prostate-specific antigen screening for prostate cancer should be patient specific, providing room for the patient's values and preferences to be incorporated in the clinical decision-making process.[@b12-ppa-12-2309]

There are several methods to determine patient's preferences, including questionnaires, interviews, and discrete choice experiments.[@b13-ppa-12-2309] Herein, we examined the use of questionnaires to obtain patient's preferences and values. Questionnaires are an important tool to survey attitudes, knowledge, and practice;[@b14-ppa-12-2309],[@b15-ppa-12-2309] to generate or refine research questions; and to evaluate the impact of clinical research in practice. Questionnaires can use a descriptive qualitative method[@b16-ppa-12-2309] to report factual data or an explanatory method[@b17-ppa-12-2309] to draw inferences and relationships between constructs or concepts. The development of patient's preference questionnaires should be performed ideally through a psychometric approach, ensuring item generation, pretest and pilot testing,[@b18-ppa-12-2309] validity,[@b19-ppa-12-2309] reliability testing,[@b20-ppa-12-2309] and acceptability[@b21-ppa-12-2309] in measuring patient's preferences and values. However, there are many factors that influence the formulation and implementation of questionnaires, including its contents, mode of administration, number of questions, time to complete, the setting of the questions, and ease of understanding.

To contribute to the development of optimal methods to design and conduct questionnaires in primary studies on patient's values and preferences, we conducted a systematic review to summarize characteristics of studies and assessed the quality of the development of questionnaires used to assess patient's preferences. Our findings will help researchers to identify the most appropriate questionnaires to use when retrieving information on patient's preferences and values in different clinical scenarios.

Methods
=======

Data sources and search strategy
--------------------------------

An electronic literature search of the MEDLINE, Embase, Web of Science, the Cochrane Library, Chinese Biomedical Database (which is considered as an equivalent of MEDLINE in China and only contains studies published in Chinese), China National Knowledge Infrastructure, and Wan Fang databases was performed, from their inception to January 2018. In addition, hand searches were accomplished in Google from the reference lists of included articles. The search was run using free-text terms and medical subject headings; the search strategy is available as supplementary material.

Eligibility criteria
--------------------

Studies were included if they 1) focused on patient's preferences and/or values and 2) included fully structured questionnaires or scales with standardized questions and answer options that were patient (self-) reported. Studies were excluded if 1) they contained incomplete questionnaires of diseases focused on patient's preferences and/or values; 2) the questionnaires reported a rating by an interviewer; or 3) they were published in a language other than Chinese or English.

Study selection
---------------

The study selection process was piloted by two independent reviewers at the beginning of the review. All titles, abstracts, and full articles were independently reviewed by more than two reviewers, and the full-text articles of relevant studies were obtained. Disagreements between the reviewers were initially resolved by consensus and when necessary by a third reviewer.

Data extraction
---------------

We developed and piloted a data extraction form to extract the data. The following information was extracted: 1) characteristics of the studies, such as the disease domain, research type, study duration, setting, patient characteristics, and the method used to calculate sample size; 2) characteristics of the questionnaires (ie, mode of administration, item generation, pilot testing, time to complete, response rates, the number of items, the setting of questions, response options, and incentive offered to respondents); and 3) the data related to conduct questionnaires (item and dimension generation, pretest and pilot testing, validity, reliability testing, and acceptability).

We abstracted the content relevant to patient's preferences into the data extraction form. After discussing and sorting discrepancies related to wording or interpretations, we summarized the domains and items about patient's preferences. Two authors (JL and FB) independently extracted the data from the questionnaires. Disagreements were initially resolved by consensus and when necessary with the help of a third reviewer (K-HY).

Data analysis and assessment
----------------------------

Two independent reviewers psychometrically assessed the identified questionnaires, determining how items and dimensions were generated and if pretests and pilot testing of the questionnaires were performed for reliability, validity, and acceptability.[@b22-ppa-12-2309]--[@b25-ppa-12-2309] These items were judged as follows: "yes" (when the criterion was explicitly met), "no" (when the criterion was explicitly not met), "uncertain" (when the item was relevant but not described completely), and "not applicable". [Table 1](#t1-ppa-12-2309){ref-type="table"} shows the details of the psychometric properties assessed. Apart from assessing the quality of the questionnaires, we used descriptive statistics to analyze the extracted data and calculated absolute frequencies and proportions for all items.

Results
=======

Study selection
---------------

[Figure 1](#f1-ppa-12-2309){ref-type="fig"} shows a flow diagram of the study selection and identification process. The electronic database search produced 6,956 references, and 52 additional references were identified through other sources. A total of 7,008 records were identified by removing duplicates after the title and abstract screening, excluding 4,974 records, and resulting in 187 articles for full-text assessment. Of these, 21 articles were excluded because they were not specific to patient's preferences and 106 articles were excluded because they had no questionnaires. In addition, seven articles were excluded because the questionnaires were incomplete. Finally, 20 articles that had complete questionnaires focusing on patient's preferences were included.

Characteristics of included studies
-----------------------------------

The final sample included 20 articles in English, published between 1999 and 2017, with study duration ranging from 2 to 20 months, including a total patient sample size of 6,300 ([Table 2](#t2-ppa-12-2309){ref-type="table"}). [Table 2](#t2-ppa-12-2309){ref-type="table"} shows the included study characteristics. Six (30%) of these studies were related to cancer diseases,[@b30-ppa-12-2309],[@b33-ppa-12-2309],[@b37-ppa-12-2309],[@b43-ppa-12-2309],[@b46-ppa-12-2309],[@b47-ppa-12-2309] and 15 (75%) were conducted in the outpatient department. Furthermore, nine (45%) studies did not report the study design,[@b30-ppa-12-2309],[@b34-ppa-12-2309],[@b38-ppa-12-2309],[@b40-ppa-12-2309],[@b41-ppa-12-2309],[@b43-ppa-12-2309],[@b44-ppa-12-2309],[@b46-ppa-12-2309] 12 (60%) studies provided training to the study participants,[@b32-ppa-12-2309]--[@b38-ppa-12-2309],[@b40-ppa-12-2309],[@b41-ppa-12-2309],[@b45-ppa-12-2309],[@b47-ppa-12-2309],[@b49-ppa-12-2309] while four (20%) studies did not report information about patient training.[@b42-ppa-12-2309]--[@b44-ppa-12-2309],[@b48-ppa-12-2309] In addition, only five (25%) studies provided the method used to calculate the sample size[@b35-ppa-12-2309]--[@b39-ppa-12-2309],[@b39-ppa-12-2309]--[@b42-ppa-12-2309],[@b42-ppa-12-2309]--[@b47-ppa-12-2309] and only six (30%) studies investigated patient's family members.[@b31-ppa-12-2309],[@b34-ppa-12-2309]--[@b37-ppa-12-2309],[@b49-ppa-12-2309] Finally, 17 (85%) studies provided information assessing patient knowledge and beliefs.30,32--35,37--45,47--49

Characteristics of questionnaires in the included studies
---------------------------------------------------------

The characteristics of questionnaires in the included studies are listed in [Table 3](#t3-ppa-12-2309){ref-type="table"}.

Most questionnaires were found to be easy to administer; 16 questionnaires (80%) were conducted through an interview survey,[@b31-ppa-12-2309]--[@b40-ppa-12-2309],[@b43-ppa-12-2309]--[@b47-ppa-12-2309],[@b49-ppa-12-2309] whereas only one questionnaire (5%) was conducted via an online survey;[@b48-ppa-12-2309] three questionnaires (15%) did not report the method used for survey administration.[@b30-ppa-12-2309],[@b41-ppa-12-2309],[@b42-ppa-12-2309] The mean number of pages per questionnaire was 4.4 (range, 1--17), the mean number of items per questionnaire was 14 (range, 2--50), and 16 (80%) questionnaires were filled anonymously.30,32--42,44,45,47--49 Further, 16 studies (80%) obtained informed consent from the patients before the study,[@b30-ppa-12-2309],[@b31-ppa-12-2309],[@b33-ppa-12-2309],[@b34-ppa-12-2309],[@b44-ppa-12-2309]--[@b49-ppa-12-2309] whereas four studies (20%) did not report if informed consent had been obtained.[@b32-ppa-12-2309],[@b35-ppa-12-2309],[@b42-ppa-12-2309],[@b43-ppa-12-2309] Most questionnaires used 4- to 7-point scales of measurement. The single-choice question format with open-ended questions and a choice task was the most common type of survey setting (25%), followed by single-choice questions with a choice task (33%). In addition, two studies[@b33-ppa-12-2309],[@b47-ppa-12-2309] (10%) reported that they used a patient incentive during the survey, of which one study[@b33-ppa-12-2309] reported that respondents were provided with a bar-code to initiate payment of \$1.00 and another study[@b47-ppa-12-2309] reported compensation of respondents with a \$15 gift card.

Questionnaire content evaluation
--------------------------------

The evaluation of contents of questionnaire is summarized in [Table 4](#t4-ppa-12-2309){ref-type="table"}.

From the included studies, 10 (50%) described the process of item generation.[@b33-ppa-12-2309],[@b35-ppa-12-2309],[@b36-ppa-12-2309],[@b38-ppa-12-2309],[@b39-ppa-12-2309],[@b41-ppa-12-2309],[@b42-ppa-12-2309],[@b44-ppa-12-2309]--[@b46-ppa-12-2309] As for pretest and pilot testing, only four questionnaires (20%) mentioned that the survey had undergone cognitive pretesting or pilot testing.[@b33-ppa-12-2309],[@b35-ppa-12-2309],[@b39-ppa-12-2309],[@b44-ppa-12-2309] Regarding validity, seven questionnaires (35%) assessed validity by asking patients if there were other aspects of care that were not mentioned in the questionnaires,[@b34-ppa-12-2309]--[@b36-ppa-12-2309],[@b42-ppa-12-2309]--[@b44-ppa-12-2309] whereas only one questionnaire (5%) assessed internal consistency using Cronbach's α with values of 0.74--0.87.[@b43-ppa-12-2309] For acceptability, the time to complete the questionnaires ranged from 10 to 30 minutes, with nine studies (45%) reporting such data.[@b35-ppa-12-2309],[@b36-ppa-12-2309],[@b38-ppa-12-2309],[@b40-ppa-12-2309],[@b42-ppa-12-2309],[@b43-ppa-12-2309],[@b47-ppa-12-2309],[@b48-ppa-12-2309] Furthermore, response rates of the questionnaires exceeded 50% as reported by 10 studies.[@b31-ppa-12-2309],[@b33-ppa-12-2309]--[@b35-ppa-12-2309],[@b38-ppa-12-2309],[@b40-ppa-12-2309],[@b42-ppa-12-2309]--[@b44-ppa-12-2309],[@b46-ppa-12-2309] In addition, only two studies showed the highest questionnaire content quality following psychometric analysis;[@b35-ppa-12-2309],[@b44-ppa-12-2309] four studies did not follow the psychometric methods to use the questionnaire measuring patient's preferences and values since neither did they describe item generation and pilot testing nor did they report the related information of validity, reliability, and acceptability.[@b30-ppa-12-2309],[@b32-ppa-12-2309],[@b37-ppa-12-2309],[@b49-ppa-12-2309]

Items and domains identified for measuring patient's preferences
----------------------------------------------------------------

[Table 5](#t5-ppa-12-2309){ref-type="table"} presents a list of domains and examples of items about patient's preferences and values in the questionnaires reviewed. We identified the items that measured patient's values and preferences and grouped them into four domains, namely effectiveness, safety, prognosis, and others. The "others" domain included information on cost, physician's experience, physician's recommendation, and initiation of the decision-making process. Some domains and items were more frequently reported than others. For example, the "effectiveness" domain was the most considered in the patient's value questionnaire (36.4%, 12/33), while the least considered domain was "physician's experience" (3.03%, 1/33).

Discussion
==========

The present study reviews the content and construction of questionnaires to provide information on the most appropriate questionnaires to assess patient's preferences and values for the development of clinical practice guidelines. Our survey of the literature showed that few questionnaires met the psychometric methodology, resulting in a low quality of content and construction of questionnaires, and that even fewer studies reported the method used to calculate the sample size. These results emphasize the importance of having a standard method available to design and conduct questionnaires to survey patient's preferences and values. Future research should follow the psychometric methodology to develop questionnaires measuring patient's preferences and values, including the main steps of item generation, pretesting or pilot testing of the initial questionnaire, and testing of the final version of the questionnaire for content validity, reliability, and acceptability. In addition, ethics statements[@b50-ppa-12-2309] of questionnaires (referring to informed consent) should be described as "written informed consent was obtained from each patient prior to study participation" or "written consent was obtained prior to initiating the survey".

Another issue identified in our systematic review was that domains and items regarding patient's preferences and values should consider effectiveness, safety, prognosis, and other factors into the formulation of patient's value and preference questionnaires.

Effectiveness
-------------

Treatment effectiveness is the most considered aspect by patients. The effectiveness domain included questions on the convenience of the treatment option, the frequency of testing, the types of drug preparations, the benefit of the intervention, treatment time, and frequency of drug administration. The benefit of the intervention was the most important factor for the majority of patients in the domain of effectiveness, followed by the convenience of the treatment option, hospital length of stay, and frequency of testing. Medication route, types of drug preparations, frequency of drug administration, and duration of treatment are important considerations when evaluating patient's preferences. These factors should be considered when designing items for patient's preference and value questionnaires.

Safety
------

The safety domain includes adverse effects, complications from interventions, and the risk of disease transmission. The risk of complications and communicating the risk of the interventions were the most important factors for the majority of patients in the domain of safety, followed by the risk of adverse effects and disease transmission. The majority of treatment options are accompanied by adverse effects, including infection, bleeding, pain, and, at the extreme, death.[@b50-ppa-12-2309]--[@b53-ppa-12-2309] Therefore, when developing questionnaires to measure patient's values and preferences, it is important to include questions on treatment safety, so that patients can make an informed decision regarding their preferred treatment. For example, Rid et al[@b35-ppa-12-2309] measured safety by asking "when your physician communicates with you about medical risk (that is, the chance or come will occur related to a probability of adverse effects and complications with specific medical intervention you are considering), which treatment would you prefer?"

Prognosis
---------

Prognosis includes the risk of relapse and the likelihood of a return to normal health following treatment. Our study recommends a detailed display of information on prognosis when formulating such questionnaires. For example, statements such as "we will ask you to think about how you would feel about these different treatments, you will be given detailed information about three treatment options that differ in terms of the risk of relapse, recovery time, and the chance of returning to normal health after treatment, which treatment would you prefer?" should be presented. In summary, all diseases and their paths vary, and patients have varying emotions, values, and preferences; therefore, prognosis factors should be considered to make more valid questionnaires on patient's values and preferences.[@b54-ppa-12-2309]

Others
------

The "others" domain included cost, physician's experience, physician's recommendation, and initiation of the decision-making process. The results showed that the financial cost or financial burden of treatment accounts for a large proportion of the questionnaire items affecting patient's values and preferences when considering treatment choice. Questionnaire developers could display the medical expenses for alternative treatments in detail to fully capture the factors influencing patient's preferences with regards to cost. In addition, the physician's recommendation and experience should be considered in the development of questionnaires on patient's preferences.

Strengths and limitations
-------------------------

This is the first study to conduct a systematic review evaluating questionnaires measuring patient's values and preferences. The results herein will provide valuable guidance to researchers and policymakers during the development of clinical practice guidelines and in the shared clinical decision-making process. The strengths of our study include explicit eligibility criteria, a comprehensive literature search, duplicate assessment of eligibility with a high agreement, and a detailed iterative process for the identification of items suggested in the reviews and categorization of items into domains.

Nevertheless, it also has several limitations. First, only studies published in English were included. Second, although we finally identified 20 complete questionnaires, it is possible that we failed to identify other eligible questionnaires due to varying terminology and suboptimal indexing of patient's preferences.

Conclusion
==========

Only a few studies have developed questionnaires with rigorous psychometric methods to measure patient's preferences and values, and there are still no valid or reliable questionnaires to do this in the process of treatment decision making and for the development of clinical practice guidelines.

Availability of data and material
=================================

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Supplementary material
======================

1.  Search strategies.

2.  Search strategies (take PubMed as an example):

3.  \#1 Search "Guidelines as Topic" \[Mesh\]

4.  \#2 Search "Practice Guidelines as Topic" \[Mesh\]

5.  \#3 Search "Guideline" \[Publication Type\]

6.  \#4 Search (((((guideline\* \[Title/Abstract\]) OR consensus \[Title/Abstract\]) OR instruction\[Title/Abstract\]) OR routine \[Title/Abstract\]) OR "clinical practice" \[Title/Abstract\]) OR "recommendation\*" \[Title/Abstract\])))))

7.  \#5 Search \#1 OR \#2 OR \#3 OR \#4

8.  \#6 Search "Patient Preference" \[Mesh\]

9.  \#7 Search patient preference\* \[Title/Abstract\]

10. \#8 Search \#6 OR \#7

11. \#9 Search "Patient Satisfaction" \[Mesh\]

12. \#10 Search Patient\* Satisfaction \[Title/Abstract\]

13. \#11 Search \#9 OR \#10

14. \#12 Search "Attitude to Health" \[Mesh\]

15. \#13 Search (attitude to health \[Title/Abstract\]) OR health attitude\* \[Title/Abstract\]

16. \#14 Search \#12 OR \#13

17. \#15 Search "Treatment Adherence and Compliance" \[Mesh\]

18. \#16 Search (adherence \[Title/Abstract\] AND compliance \[Title/Abstract\])

19. \#17 Search \#15 OR \#16

20. \#18 Search patient decision \[Title/Abstract\]

21. \#19 Search patient acceptance \[Title/Abstract\]

22. \#20 Search "Patient Acceptance of Health Care" \[Mesh\]

23. \#21 Search \#19 OR \#20

24. \#22 Search patient perspective \[Title/Abstract\]

25. \#23 Search health state utilit\* \[Title/Abstract\]

26. \#24 Search \#8 OR \#11 OR \#14 OR \#17 OR \#18 OR \#21 OR \#22 OR \#23

27. \#25 Search \#5 AND \#24
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AGREE II

:   Appraisal of Guidelines Research and Evaluation II

NR

:   not reported

ACL

:   anterior cruciate ligament reconstruction

ADHD

:   attention deficit/hyperactivity disorder

RA

:   rheumatoid arthritis

T2DM

:   type 2 diabetes mellitus

T1DM

:   type 1 diabetes mellitus

ICD

:   implantable cardioverter-defibrillators

CML

:   chronic myeloid leukemia

SCQ

:   single-choice question

OeQ

:   subjective question

MCQ

:   multiple-choice question
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###### 

Items of the psychometric methods

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------
  **1. Item and dimension generation**                                                                                                                                                                                                                                                                                                                                                                 
  The item generation phase should include all important elements of patient's preferences by reviewing the existing questionnaires, literature, and opinions from experts and patient focus groups. The authors should describe the generation of initial items, including literature review,[@b26-ppa-12-2309] the Delphi survey,[@b27-ppa-12-2309] and consensus meetings,[@b28-ppa-12-2309] etc.   ⎕ Yes
  ⎕ No                                                                                                                                                                                                                                                                                                                                                                                                 
  ⎕ Uncertain                                                                                                                                                                                                                                                                                                                                                                                          
  ⎕ Not applicable                                                                                                                                                                                                                                                                                                                                                                                     
  **2. Pretest and pilot testing**                                                                                                                                                                                                                                                                                                                                                                     
  The authors should state that they pretested the items of questionnaires. The process of pretest and pilot testing is for revision of the questionnaire into the final validated version by using the response from the protest group. Items with ambiguous meanings can be eliminated to maximize the reliability and validity of the questionnaire.                                                ⎕ Yes
  ⎕ No                                                                                                                                                                                                                                                                                                                                                                                                 
  ⎕ Uncertain                                                                                                                                                                                                                                                                                                                                                                                          
  ⎕ Not applicable                                                                                                                                                                                                                                                                                                                                                                                     
  **3. Validity testing**                                                                                                                                                                                                                                                                                                                                                                              
  **Content validity**. It is usually reported in questionnaires judged by the panel after literature reviews and focus group interviews. During the testing phase, patients are asked to review the items in the questionnaire for content validity on patient's values and preferences before it is administered to study participants.                                                              ⎕ Yes
  ⎕ No                                                                                                                                                                                                                                                                                                                                                                                                 
  ⎕ Uncertain                                                                                                                                                                                                                                                                                                                                                                                          
  **Construct validity**. Because there is no standard for measuring patient's satisfaction, researchers usually compare their questionnaire with other validated instruments or other related questions for this correlation. Discriminant validity requires that the construct should not show correlation with dissimilar variables.                                                                ⎕ Not applicable
  **4. Reliability testing**                                                                                                                                                                                                                                                                                                                                                                           
  The authors should state that they tested the reliability.                                                                                                                                                                                                                                                                                                                                           ⎕ Yes
  **Internal consistency**. Cronbach's α should be reported, the value should be 0.7--0.9, as a value above 0.9 may indicate that the questionnaire is too narrow in scope.                                                                                                                                                                                                                            ⎕ No
  ⎕ Uncertain                                                                                                                                                                                                                                                                                                                                                                                          
  **Test-retest reliability**. The minimum value of the correlation coefficient should be 0.7.                                                                                                                                                                                                                                                                                                         ⎕ Not applicable
  **Intrarater and interrater agreements**. Intrarater agreement is the agreement between observations made by the same rater on two different occasions.                                                                                                                                                                                                                                              
  **5. Feasibility/acceptability**                                                                                                                                                                                                                                                                                                                                                                     
  **Time to complete**. The authors should provide the time to complete the questionnaires.                                                                                                                                                                                                                                                                                                            ⎕ Yes
  ⎕ No                                                                                                                                                                                                                                                                                                                                                                                                 
  **Response rates**. The authors should provide the response rates of the questionnaires. A response rate of 50% is considered adequate for analysis.[@b29-ppa-12-2309]                                                                                                                                                                                                                               ⎕ Uncertain
  ⎕ Not applicable                                                                                                                                                                                                                                                                                                                                                                                     
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------

###### 

Characteristics of included studies

  Author (year)                               Disease domain       Study design                                       Study duration (months)   Setting                No of patients   Provided training to patients   Calculated sample size   Involved family members   Examined knowledge about diseases
  ------------------------------------------- -------------------- -------------------------------------------------- ------------------------- ---------------------- ---------------- ------------------------------- ------------------------ ------------------------- -----------------------------------
  Bo et al (2014)[@b30-ppa-12-2309]           Lung cancer          NR                                                 19                        Inpatient              135              NR                              NR                       No                        Yes
  Welsh and Tiffin (2014)[@b31-ppa-12-2309]   Psychosis            Brief self-report survey                           3                         NR                     75               NR                              NR                       Yes                       No
  Vu et al (2015)[@b32-ppa-12-2309]           Colonoscopy          Single-center, prospective survey                  NR                        Outpatient             500              Yes                             NR                       No                        Yes
  Tong et al (2016)[@b33-ppa-12-2309]         Lung cancer          Pilot study                                        NR                        NR                     225              Yes                             NR                       No                        Yes
  Sekimoto et al (2004)[@b34-ppa-12-2309]     T2DM                 NR                                                 3                         Outpatient             133              Yes                             NR                       Yes                       Yes
  Rid et al (2015)[@b35-ppa-12-2309]          Incapacity           Self-administered quantitative survey              20                        Inpatient Outpatient   1,116            Yes                             Yes                      No                        Yes
  Noble et al (2015)[@b36-ppa-12-2309]        Thrombosis           Conjoint analysis surveys                          NR                        Inpatient              100              Yes                             Yes                      No                        No
  Mazur et al (1999)[@b37-ppa-12-2309]        Prostate cancer      Cross-sectional study                              NR                        Outpatient             228              Yes                             NR                       No                        Yes
  Matti et al (2010)[@b38-ppa-12-2309]        Optic neuritis       NR                                                 5                         Outpatient             27               Yes                             NR                       No                        Yes
  Maciver et al (2016)[@b39-ppa-12-2309]      Heart failure        Qualitative study                                  12                        Outpatient             25               NR                              Yes                      No                        Yes
  Sanford et al (2014)[@b40-ppa-12-2309]      Myeloid leukemia     NR                                                 3                         Outpatient             56               Yes                             NR                       Yes                       Yes
  Koh et al (2010)[@b41-ppa-12-2309]          ACL reconstruction   NR                                                 22                        Outpatient             129              Yes                             NR                       No                        Yes
  Ha and Mcdonald (2017)[@b42-ppa-12-2309]    Preterm birth        Cross-sectional survey                             2                         Outpatient             311              No                              Yes                      Yes                       Yes
  Gareen et al (2015)[@b43-ppa-12-2309]       Colorectal cancer    NR                                                 12                        Outpatient             2,310            No                              NR                       No                        Yes
  Fiks et al (2013)[@b44-ppa-12-2309]         ADHD                 NR                                                 6                         Outpatient             148              No                              NR                       Yes                       Yes
  Eckman et al (2015)[@b45-ppa-12-2309]       Thrombus             Cross-sectional study                              NR                        Outpatient             123              Yes                             NR                       No                        Yes
  Choudhry et al (2015)[@b46-ppa-12-2309]     Melanoma             NR                                                 12                        Outpatient             301              NR                              NR                       No                        No
  Calderwood et al (2011)[@b47-ppa-12-2309]   Colorectal cancer    Cross-sectional survey                             14                        Outpatient             100              Yes                             Yes                      No                        Yes
  Bolge et al (2016)[@b48-ppa-12-2309]        RA                   Self-administered online survey                    NR                        Outpatient             243              No                              NR                       No                        Yes
  Hofman et al (2011)[@b49-ppa-12-2309]       T1DM                 Open-label, randomized, crossover usability test   NR                        Inpatient              15               Yes                             NR                       Yes                       Yes

**Abbreviations:** ACL, anterior cruciate ligament reconstruction; ADHD, attention deficit/hyperactivity disorder; NR, not reported; RA, rheumatoid arthritis; T1DM, type 1 diabetes mellitus; T2DM, type 2 diabetes mellitus.

###### 

Characteristics of included questionnaires

  Questionnaire from studies                  Mode of administration   Format   Incentives   Ethics statement                                                                                                                                                                                                   
  ------------------------------------------- ------------------------ -------- ------------ ------------------ --- ------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------- ----- ----- -----
  Bo et al (2014)[@b30-ppa-12-2309]           NR                       9        1            SCQ                2   --                                    --                                                                                                                                        NR    Yes   Yes
  Welsh and Tiffin (2014)[@b31-ppa-12-2309]   Interview                10       3            CT                 4   4-point scale (10)                    Very likely, likely, unlikely, very unlikely                                                                                              NR    NR    Yes
  Vu et al (2015)[@b32-ppa-12-2309]           Interview                12       2            SCQ+CT+OeQ         2   4-point scale (3)                     Very important to not important at all                                                                                                    NR    Yes   NR
  Tong et al (2016)[@b33-ppa-12-2309]         Interview                50       17           SCQ+CT             4   5-point scale (3)                     Strongly prefer left, somewhat prefer left, indifferent, somewhat prefer right, strongly prefer right                                     Yes   Yes   Yes
  Sekimoto et al (2004)[@b34-ppa-12-2309]     Interview                7        2            SCQ+CT             2   --                                    --                                                                                                                                        NR    Yes   Yes
  Rid et al (2015)[@b35-ppa-12-2309]          Interview                46       6            SCQ+CT+OeQ         4   4-point scale (23)                    Extremely important, moderately important, just a little important, not important at all                                                  NR    Yes   NR
  Noble et al (2015)[@b36-ppa-12-2309]        Interview                10       7            SCQ+CT+OeQ         2   5-point scale (10)                    Do not agree at all to fully agree                                                                                                        NR    Yes   Yes
  Mazur et al (1999)[@b37-ppa-12-2309]        Interview                2        1            SCQ+OeQ            1   --                                    --                                                                                                                                        NR    NR    Yes
  Matti et al (2010)[@b38-ppa-12-2309]        Interview                19       3            MCQ+SCQ            3   --                                    --                                                                                                                                        NR    Yes   Yes
  Maciver et al (2016)[@b39-ppa-12-2309]      Interview                6        3            SCQ+OeQ            2   --                                    --                                                                                                                                        NR    Yes   Yes
  Sanford et al (2014)[@b40-ppa-12-2309]      Interview                18       4            SCQ+CT+OeQ         5   5-point scale (11)                    Nil, minor, tolerable, tolerable but I adjust my activities or take medications for it, intolerable                                       NR    Yes   Yes
  Koh et al (2010)[@b41-ppa-12-2309]          NR                       7        1            MCQ+SCQ            1   --                                    --                                                                                                                                        NR    Yes   Yes
  Ha and Mcdonald (2017)[@b42-ppa-12-2309]    NR                       17       6            SCQ+CT             6   5-point scale (3)                     Extremely important, slightly important, neutral, slightly not important, not at all important                                            NR    Yes   NR
  Gareen et al (2015)[@b43-ppa-12-2309]       Interview                3        9            SCQ+OeQ            6   --                                    --                                                                                                                                        NR    NR    NR
  Fiks et al (2013)[@b44-ppa-12-2309]         Interview                9        1            CT                 3   6-point scale (9)                     Not at all, a little, somewhat, very much, completely                                                                                     NR    Yes   Yes
  Eckman et al (2015)[@b45-ppa-12-2309]       Interview                2        1            SCQ                2   --                                    --                                                                                                                                        NR    Yes   Yes
  Choudhry et al (2015)[@b46-ppa-12-2309]     Interview                11       4            SCQ+CT+OeQ         3   --                                    --                                                                                                                                        NR    No    Yes
  Calderwood et al (2011)[@b47-ppa-12-2309]   Interview                20       12           SCQ+CT             3   5-point scale (13)                    Strongly agree, agree, neither agree nor disagree, disagree, strongly disagree                                                            Yes   Yes   Yes
  Bolge et al (2016)[@b48-ppa-12-2309]        online survey            11       3            SCQ+CT             2   5-point scale (2) 4-point scale (1)   Not at all open, not very open, somewhat open, very open, extremely open; strongly prefer self-injection to strongly prefer IV infusion   NR    Yes   Yes
  Hofman et al (2011)[@b49-ppa-12-2309]       Interview                13       2            CT+OeQ             2   6-point scale (13)                    Very difficult--very easy; not at all likely--very likely                                                                                 NR    Yes   Yes

**Abbreviations:** CT, choice task; IV, intravenous; MCQ, multiple-choice question; NR, not reported; OeQ, open-ended question; SCQ, single-choice question.

###### 

The evaluation of components of questionnaires

                                              Item generation   Pilot testing and redesign   Validity testing   Reliability testing (Cronbach's α)   Acceptability   
  ------------------------------------------- ----------------- ---------------------------- ------------------ ------------------------------------ --------------- -----
                                                                                                                                                                     
  Bo et al (2014)[@b30-ppa-12-2309]           No                No                           No                 No                                   No              No
  Welsh and Tiffin (2014)[@b31-ppa-12-2309]   No                No                           No                 No                                   No              Yes
  Vu et al (2015)[@b32-ppa-12-2309]           No                No                           No                 No                                   No              No
  Tong et al (2016)[@b33-ppa-12-2309]         Yes               Yes                          No                 No                                   Yes             Yes
  Sekimoto et al (2004)[@b34-ppa-12-2309]     No                No                           Yes                No                                   No              Yes
  Rid et al (2015)[@b35-ppa-12-2309]          Yes               Yes                          Yes                No                                   Yes             Yes
  Noble et al (2015)[@b36-ppa-12-2309]        Yes               No                           Yes                No                                   Yes             No
  Mazur et al (1999)[@b37-ppa-12-2309]        No                No                           No                 No                                   No              No
  Matti et al (2010)[@b38-ppa-12-2309]        Yes               No                           No                 No                                   Yes             Yes
  Maciver et al (2016)[@b39-ppa-12-2309]      Yes               Yes                          No                 No                                   No              No
  Sanford et al (2014)[@b40-ppa-12-2309]      No                No                           No                 No                                   Yes             Yes
  Koh et al (2010)[@b41-ppa-12-2309]          Yes               No                           Yes                No                                   No              No
  Ha and Mcdonald (2017)[@b42-ppa-12-2309]    Yes               No                           Yes                No                                   Yes             Yes
  Gareen et al (2015)[@b43-ppa-12-2309]       No                No                           Yes                No                                   Yes             Yes
  Fiks et al (2013)[@b44-ppa-12-2309]         Yes               Yes                          Yes                Yes                                  No              Yes
  Eckman et al (2015)[@b45-ppa-12-2309]       Yes               No                           No                 No                                   No              No
  Choudhry et al (2015)[@b46-ppa-12-2309]     Yes               No                           No                 No                                   No              Yes
  Calderwood et al (2011)[@b47-ppa-12-2309]   No                No                           No                 No                                   Yes             No
  Bolge et al (2016)[@b48-ppa-12-2309]        No                No                           No                 No                                   Yes             No
  Hofman et al (2011)[@b49-ppa-12-2309]       No                No                           No                 No                                   No              No

###### 

Summary of domains and items for reviewing the questionnaires addressing values and preferences

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Domain                                        Study ID, author (year)                                                                                                                                                                                                                                                                                                                                               Examples                                                                                                                                                                                                                                                                                                                                                               Scale                       Type of disease
  --------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------- ------------------------------
  **Effectiveness**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  The convenience of treatment                  Bolge et al (2016)[@b48-ppa-12-2309]                                                                                                                                                                                                                                                                                                                                  Would you prefer to take your biologic medication by self-injection at home or have the medication given to you by a health care professional through intravenous infusion?\                                                                                                                                                                                           5-point scale               RA
                                                                                                                                                                                                                                                                                                                                                                                                                      1=strongly prefer self-injection, 2=somewhat prefer self-injection, 3=no preference between self-injection and intravenous infusion, 4=somewhat prefer intravenous infusion, 5=strongly prefer the intravenous infusion                                                                                                                                                                            

  Hofman et al (2011)[@b49-ppa-12-2309]         How easy or difficult it was to detach/remove the needle cap?\                                                                                                                                                                                                                                                                                                        6-point scale                                                                                                                                                                                                                                                                                                                                                          Adolescents with diabetes   
                                                1=very difficult, 6=very easy                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  The frequency required for testing            Calderwood et al (2011)[@b47-ppa-12-2309]                                                                                                                                                                                                                                                                                                                             Which of the following attributes most influences your choice?\                                                                                                                                                                                                                                                                                                        SCQ                         Colorectal cancer
                                                                                                                                                                                                                                                                                                                                                                                                                      The frequency required for testing\                                                                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                                                                                                                                                                                                                                                                      Liability concerns\                                                                                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                                                                                                                                                                                                                                                                      Cost of test/coverage\                                                                                                                                                                                                                                                                                                                                                                             
                                                                                                                                                                                                                                                                                                                                                                                                                      Complication rates                                                                                                                                                                                                                                                                                                                                                                                 

  The types of drug preparations and therapy    Welsh and Tiffin (2014)[@b31-ppa-12-2309]                                                                                                                                                                                                                                                                                                                             How likely would you be to accept this kind of support?\                                                                                                                                                                                                                                                                                                               4-point scale               Psychosis
                                                                                                                                                                                                                                                                                                                                                                                                                      Usually given as tablets\                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                                                                                                                                                                                                                                                                                                                                      Tablet or liquid format Talking therapy                                                                                                                                                                                                                                                                                                                                                            

  The benefit of the interventions              Ha and Mcdonald (2017)[@b42-ppa-12-2309]                                                                                                                                                                                                                                                                                                                              Did the medication work very well? (extremely important, slightly important, neutral, slightly not important, not at all important)                                                                                                                                                                                                                                    5-point scale               Premature or early birth

  Ha and Mcdonald (2017)[@b42-ppa-12-2309]      When considering cerclage treatment, how important or unimportant is each of the following\                                                                                                                                                                                                                                                                           5-point scale                                                                                                                                                                                                                                                                                                                                                          Premature or early birth    
                                                Whether the medication works well (extremely important, slightly important, neutral, slightly not important, not at all important)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  Sekimoto et al (2004)[@b34-ppa-12-2309]       Regarding the treatment options, what kind of information do you require?\                                                                                                                                                                                                                                                                                            SCQ                                                                                                                                                                                                                                                                                                                                                                    T2DM                        
                                                Risks and benefits\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                Outcome probabilities\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                Name of the famous specialist\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                Prognosis\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                Physician's recommendations                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  Treatment time                                Tong et al (2016)[@b33-ppa-12-2309]                                                                                                                                                                                                                                                                                                                                   If these procedures were identical in all other ways, which would you prefer?\                                                                                                                                                                                                                                                                                         SCQ                         Lung cancer
                                                                                                                                                                                                                                                                                                                                                                                                                      Open surgery: 3 hours\                                                                                                                                                                                                                                                                                                                                                                             
                                                                                                                                                                                                                                                                                                                                                                                                                      Minimally invasive surgery: 3 hours\                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                                                                                                                                                                                                                      Focused radiation: 1-hour outpatient visit                                                                                                                                                                                                                                                                                                                                                         

  Tong et al (2016)[@b33-ppa-12-2309]           What bothers you the most about focus radiation?\                                                                                                                                                                                                                                                                                                                     SCQ                                                                                                                                                                                                                                                                                                                                                                    Lung cancer                 
                                                Need to be still for 1 hour for each treatment\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                The tumor is not removed, only killed\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                Difficult traveling for outpatient treatments                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  The frequency of drug administration          Noble et al (2015)[@b36-ppa-12-2309]                                                                                                                                                                                                                                                                                                                                  Which frequency of administration do you prefer?\                                                                                                                                                                                                                                                                                                                      SCQ                         Cancer-associated thrombosis
                                                                                                                                                                                                                                                                                                                                                                                                                      Twice daily (duration of action over 24 hours)\                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                      Once daily (duration of action over 12 hours)                                                                                                                                                                                                                                                                                                                                                      

  Sanford et al (2014)[@b40-ppa-12-2309]        How likely are you to take your medications every day?\                                                                                                                                                                                                                                                                                                               5-point scale                                                                                                                                                                                                                                                                                                                                                          CML                         
                                                Very unlikely, unlikely, neither unlikely nor likely, likely, very likely                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                

  Hospital stay time                            Tong et al (2016)[@b33-ppa-12-2309]                                                                                                                                                                                                                                                                                                                                   What bothers you the most about open surgery?\                                                                                                                                                                                                                                                                                                                         SCQ                         Lung cancer
                                                                                                                                                                                                                                                                                                                                                                                                                      5-night hospital stay\                                                                                                                                                                                                                                                                                                                                                                             
                                                                                                                                                                                                                                                                                                                                                                                                                      6- to 8-week recovery time at home                                                                                                                                                                                                                                                                                                                                                                 

  **Safety**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  The risk of adverse effects                   Bo et al (2014)[@b30-ppa-12-2309]                                                                                                                                                                                                                                                                                                                                     Reasons for treatment decision making (choose the three answers with the most consideration):\                                                                                                                                                                                                                                                                         SCQ                         Lung cancer
                                                                                                                                                                                                                                                                                                                                                                                                                      Fewest side effects\                                                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                                                                                                                                                                                                                      Physician's recommendation\                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                      Least painful                                                                                                                                                                                                                                                                                                                                                                                      

  The risk of complications                     Ha and Mcdonald (2017)[@b42-ppa-12-2309]                                                                                                                                                                                                                                                                                                                              When considering cerclage treatment, how important or unimportant is each of the following:\                                                                                                                                                                                                                                                                           5-point scale               Premature or early birth
                                                                                                                                                                                                                                                                                                                                                                                                                      Concerns about potential harm to the baby (extremely important, slightly important, neutral, slightly not important, not at all important)                                                                                                                                                                                                                                                         

  Calderwood et al (2011)[@b47-ppa-12-2309]     Which of the following attributes mostly influences your choice?\                                                                                                                                                                                                                                                                                                     5-point scale                                                                                                                                                                                                                                                                                                                                                          Colorectal cancer           
                                                The frequency required for testing\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                Liability concerns\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                Cost of test/coverage\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                Complication rates                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  Communicating the risk of the interventions   Mazur et al (1999)[@b37-ppa-12-2309]                                                                                                                                                                                                                                                                                                                                  Which do you prefer when your physician communicates to you the risk of the intervention?\                                                                                                                                                                                                                                                                             SCQ                         Lung cancer
                                                                                                                                                                                                                                                                                                                                                                                                                      Words Numbers Other                                                                                                                                                                                                                                                                                                                                                                                

  Sekimoto et al (2004)[@b34-ppa-12-2309]       Regarding the treatment options, what kind of information do you require?\                                                                                                                                                                                                                                                                                            SCQ                                                                                                                                                                                                                                                                                                                                                                    T2DM                        
                                                Risks and benefits\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                Outcome probabilities\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                Name of the famous specialist\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                Prognosis\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                Physician's recommendations                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  The risk of disease transmission              Koh et al (2010)[@b41-ppa-12-2309]                                                                                                                                                                                                                                                                                                                                    If you choose the allograft, what are the reasons for it?\                                                                                                                                                                                                                                                                                                             MCQ                         ACL reconstruction
                                                                                                                                                                                                                                                                                                                                                                                                                      Better healing after grafting\                                                                                                                                                                                                                                                                                                                                                                     
                                                                                                                                                                                                                                                                                                                                                                                                                      Less expensive\                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                      No risk of tissue rejection or disease transmission Surgeon's explanation                                                                                                                                                                                                                                                                                                                          

  **Prognosis**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  The risk of relapse                           Sanford et al (2014)[@b40-ppa-12-2309]                                                                                                                                                                                                                                                                                                                                In the following questions, if the risk of relapse is different, how likely are you to stop medications for your CML? If the risk of relapse were 20%, 40%, 60%?, I would absolutely stop, I would likely stop, I would be neutral, I would likely not stop, I would absolutely not stop                                                                               SCQ                         CML

  Sekimoto et al (2004)[@b34-ppa-12-2309]       Regarding the treatment options, what kind of information do you require?\                                                                                                                                                                                                                                                                                            SCQ                                                                                                                                                                                                                                                                                                                                                                    T2DM                        
                                                Risks and benefits\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                Outcome probabilities\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                Name of the famous specialist Prognosis\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
                                                Physician's recommendations                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  Matti et al (2010)[@b38-ppa-12-2309]          What is your view about having an action plan in the event of a relapse?\                                                                                                                                                                                                                                                                                             SCQ                                                                                                                                                                                                                                                                                                                                                                    Optic neuritis              
                                                Not interested, may be useful but unsure, will consider, will definitely have an action plan                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  Better healing after treatment/recover time   Koh et al (2010)[@b41-ppa-12-2309]                                                                                                                                                                                                                                                                                                                                    If you choose the allograft, what are the reasons for it?\                                                                                                                                                                                                                                                                                                             MCQ                         ACL
                                                                                                                                                                                                                                                                                                                                                                                                                      Better healing after grafting\                                                                                                                                                                                                                                                                                                                                                                     
                                                                                                                                                                                                                                                                                                                                                                                                                      Less expensive\                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                      No risk of tissue rejection or disease transmission\                                                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                                                                                                                                                                                                                      Surgeon's explanation                                                                                                                                                                                                                                                                                                                                                                              

  **Others**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  The cost patients have to pay                 Ha and Mcdonald (2017)[@b42-ppa-12-2309]                                                                                                                                                                                                                                                                                                                              When considering cerclage treatment, how important or unimportant is each of the following\                                                                                                                                                                                                                                                                            5-point scale               Premature or early birth
                                                                                                                                                                                                                                                                                                                                                                                                                      Whether there would be a cost for you (extremely important, slightly important, neutral, slightly not important, not at all important)                                                                                                                                                                                                                                                             

  Calderwood et al (2011)[@b47-ppa-12-2309]     Which of the following attributes mostly influences your choice?\                                                                                                                                                                                                                                                                                                     SCQ                                                                                                                                                                                                                                                                                                                                                                    Colorectal cancer           
                                                The frequency required for testing\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                Liability concerns\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                Cost of test/coverage\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                Complication rates                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  Koh et al (2010)[@b41-ppa-12-2309]            If you choose the allograft, what are the reasons for it?\                                                                                                                                                                                                                                                                                                            MCQ                                                                                                                                                                                                                                                                                                                                                                    ACL reconstruction          
                                                Better healing after grafting\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                Less expensive\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                No risk of tissue rejection or disease transmission\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                Surgeon's explanation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    

  Physician's experience                        Tong et al (2016)[@b33-ppa-12-2309]                                                                                                                                                                                                                                                                                                                                   How important is your physician's experience to you?\                                                                                                                                                                                                                                                                                                                  4-point scale               Lung cancer
                                                                                                                                                                                                                                                                                                                                                                                                                      Unimportant compared with other factors, somewhat important, very important, extremely important                                                                                                                                                                                                                                                                                                   

  Physician's recommendation                    Bolge et al (2016)[@b48-ppa-12-2309]                                                                                                                                                                                                                                                                                                                                  When deciding on a treatment for rheumatoid arthritis, which of the following best applies?\                                                                                                                                                                                                                                                                           5-point scale               RA
                                                                                                                                                                                                                                                                                                                                                                                                                      1=I make the final treatment decision, 2=I make the final treatment decision after considering my rheumatologist's recommendations, 3=I share responsibility with my rheumatologist when deciding on a treatment, 4=my rheumatologist makes the final treatment decision, but seriously considers my opinion, 5=I leave all treatment decisions to my rheumatologist                               

  Bolge et al (2016)[@b48-ppa-12-2309]          How open are you to having your RA medication administered at home by self-injection if your rheumatologist suggested it?\                                                                                                                                                                                                                                            5-point scale                                                                                                                                                                                                                                                                                                                                                          RA                          
                                                1=not at all open, 2=not very open, 3=somewhat open, 4=very open, 5=extremely open                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  Sekimoto et al (2004)[@b34-ppa-12-2309]       Regarding the treatment options, what kind of information do you require?\                                                                                                                                                                                                                                                                                            SCQ                                                                                                                                                                                                                                                                                                                                                                    T2DM                        
                                                Risks and benefits\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                Outcome probabilities\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                Name of the famous specialist\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                Prognosis\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                                                Physician's recommendations                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  Bolge et al (2016)[@b48-ppa-12-2309]          When deciding on a treatment for rheumatoid arthritis, which of the following best applies?\                                                                                                                                                                                                                                                                          5-point scale                                                                                                                                                                                                                                                                                                                                                          RA                          
                                                1=I make the final treatment decision, 2=I make the final treatment decision after considering my rheumatologist's recommendations,3=I share responsibility with my rheumatologist when deciding on a treatment, 4=my rheumatologist makes the final treatment decision, but seriously considers my opinion, 5=I leave all treatment decisions to my rheumatologist                                                                                                                                                                                                                                                                                                                                                                                                      

  Koh et al (2010)[@b41-ppa-12-2309]            If you choose the allograft, what are the reasons for it?\                                                                                                                                                                                                                                                                                                            MCQ                                                                                                                                                                                                                                                                                                                                                                    ACL reconstruction          
                                                Better healing after grafting\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                Less expensive\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                No risk of tissue rejection or disease transmission\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                Surgeon's explanation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    

  Bo et al (2014)[@b30-ppa-12-2309]             Reasons for treatment decision-making: (choose the three answers with the most consideration)\                                                                                                                                                                                                                                                                        SCQ                                                                                                                                                                                                                                                                                                                                                                    Lung cancer                 
                                                Fewest side effects\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                Physician's recommendation\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                Least painful                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  Initiation of the decision process            Maciver et al (2016)[@b39-ppa-12-2309]                                                                                                                                                                                                                                                                                                                                Who do you think should start these discussions?\                                                                                                                                                                                                                                                                                                                      OeQ                         ICD treatment
                                                                                                                                                                                                                                                                                                                                                                                                                      Would you want the physician to wait until you asked about it or would you want the physician to start the discussion?                                                                                                                                                                                                                                                                             
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Abbreviations:** ACL, anterior cruciate ligament; CML, chronic myeloid leukemia; ICD, implantable cardioverter-defibrillators; MCQ, multiple-choice question; OeQ, subjective questions; RA, rheumatoid arthritis; SCQ, single-choice questions; T2DM, type 2 diabetes mellitus.
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